In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Think Tank: Mastering metrics
In this article Rebecca A Rozich, Director, Client Engagement & Medical Strategy at ICON shares how to effectively measure the true impact of campaigns across social media, disease education and marketing initiatives.
-
Streamlining bioprocesses with automation
In this article from BioPharm International, Ronan Fox, Senior Vice President, IT R&D, provides commentary on the evolving role of automation in biopharmaceutical development.
-
DCT Tracker: Charting the next chapter for decentralisation
More than four years after decentralisation became a necessity in the clinical trials space, the sector is still finding its way around decentralised clinical trials (DCTs). And like any other paradigm shift, the journey has taken several turns.
-
Liver disease, obesity and the value of treatment
This article by Dr Alan Baldridge and Jolanta M. Wichary, discusses the link between obesity and metabolic-dysfunction associated steatotic liver disease (MASLD), and touches on recent advancements in effective treatments for obesity.
-
ACRO Good Clinical Podcast: Paediatric clinical trials: Compassion in action
Jacqui Whiteway, Senior Director & Paediatric Strategy Liaison, Centre for Paediatric Clinical Development at ICON participates in this discussion on what makes paediatric clinical trials unique and how the industry can make participation easier for paediatric patients and their families.
-
Interview with Andy Coravos
In this article from INTELLIGENT health.tech, Andy Coravos, founder of HumanFirst, recently acquired by ICON, shares insights on leveraging digital health technologies and wearables to manage chronic conditions. Drawing from her recent Lancet Digital Health review, Coravos highlights the potential of smartwatches and fitness trackers in improving patient outcomes and easing the burden on healthcare systems.
-
Symphony Health RWD utilized to determine prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease
Real world data from Symphony Health, an ICON plc company, was used in this retrospective, observational study on prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease. These results may help healthcare providers to determine the underlying risk of tendon injuries and guide treatment of this patient population.
-
Engaging minority communities: collaborative practises and long-term success
Rare diseases can disproportionately affect minorities, yet these communities are often underrepresented in clinical studies. ICON’s experts suggest ways to improve engagement and diversity.
-
Human-enabled AI driving enhancements in clinical trial site selection
In this piece from Clinical Trial Vanguard, Travis Caudill, Vice President, Feasibility, Site Identification & Clinical Informatics explores the improvements in site selection that human-enabled AI is delivering.
-
Pharma’s obsession with obesity on rise
ICON experts, Jack Martin and Simon Bruce share insights with BioSpectrum Asia on emerging trends in obesity treatment and the future implications for pharma.
